In Brief
Mutations in the CARMA2 gene (CARD14) are identified in psoriasis patients, but whether and how these mutations initiate psoriasis is unclear. Wang et al. reveal that Card14
E138A/+ mice develop spontaneous psoriasis via CARMA2 selfaggregation and activation, and the deficiency or mutation of Card14 affects the activation of IL-17A signaling in keratinocytes.
INTRODUCTION
Psoriasis is a common chronic inflammatory skin disease mediated by both the innate and adaptive immune systems and affects approximately 2% of the worldwide population (Crow, 2012a; Lowes et al., 2014) . The histological features of psoriasis are mainly characterized by exaggerated angiogenesis, excessive growth, aberrant differentiation of keratinocytes, and brisk immune cell infiltration (Nestle et al., 2009; Perera et al., 2012; Wagner et al., 2010) . However, the exact mechanisms for the initiation of psoriasis remain elusive, mainly because of the difficulty for obtaining psoriasis samples at the initiation stage (Lowes et al., 2014) . LL37 can bind to nucleic acids to activate plasmacytoid dendritic cells (pDCs) resulting in psoriasis, suggesting that DCs might be the initiating cells of psoriasis (Lande et al., 2007; Lowes et al., 2014) . The imiquimod- (Cai et al., 2011; van der Fits et al., 2009 ) and interleukin-23 (IL-23)- (Chan et al., 2006) induced psoriasis-like skin inflammation in mice provides two experimental models that highlight the essential role of IL-23-IL-17 axis in maintenance phases of psoriasis (Cai et al., 2011; Ha et al., 2014; Riol-Blanco et al., 2014) . Antagonists of IL-23 (Crow, 2012b; Reich et al., 2017) and IL-17 (Lebwohl et al., 2015; Mease et al., 2017; van de Kerkhof et al., 2016) showed good treatment effects, which also validates the important role of the IL-23-IL-17 axis in psoriasis pathogenesis (Kim and Krueger, 2017; Riol-Blanco et al., 2014) . Consistent with these findings, a number of psoriasis susceptibility genes were mapped to the IL-23-IL-17 axis, such as IL12B, IL23A, IL23R, JAK2, and TYK2 (Harden et al., 2015; O'Rielly and Rahman, 2014; Tsoi et al., 2012) . Other studies also showed that CCR6 + cells and the ligand for CCR6 and CCL20 are essential for IL-23 induced psoriasis (Hedrick et al., 2009; Mabuchi et al., 2013) . Many psoriasis-susceptible loci are mapped to the NF-kB signaling pathway in, such as CARD14, TRAF3IP2, TNIP1, TNFAIP3, and c-REL (Garber, 2012; Tsoi et al., 2012) , suggesting a pivotal role of NF-kB signaling in psoriasis occurrence. CARD14 (encoding CARMA2 [CARD-containing MAGUK protein 2]) is a gene that is mainly expressed in the epidermis. Bowcock and co-workers found that CARD14 is located in the psoriasis susceptibility locus 2 (PSORS2) (Garber, 2012; Jordan et al., 2012b; Perera et al., 2012; Tsoi et al., 2012) . Importantly, about 20 CARD14 variants, including c.349G>A and c.413A>C, were detected in psoriasis patients (Garber, 2012; Jordan et al., 2012a; Jordan et al., 2012b) . Among these variants, the c.413A>C (p.Glu138Ala, short as E138A) mutation, identified in a child with a severe psoriasis phenotype, could induce a relatively stronger NF-kB activation compared to other mutations Jordan et al., 2012b) . It is known that CARMA2 serves as a scaffold protein to form a complex with Bcl10 and MALT1 (Lin and Wang, 2004) to recruit downstream signaling components, leading to the activation of MAPK and NF-kB signaling Howes et al., 2016) . Nevertheless, it remains to be determined whether and how these CARMA2 mutations contribute to the development and pathogenesis of psoriasis.
In this study, we found that both Card14 E138A/+ and Card14 DQ136/+ mice developed spontaneous psoriasis-like skin inflammation with increased lymphocyte infiltration and cytokine expression. We also found that Card14 À/À mice attenuated skin inflammation in response to imiquimod (IMQ) treatment, and CARMA2 associated with the adaptor molecules ACT1 and TRAF6 to mediate IL-17A-induced MAPK and NF-kB activation. Thus, our study shows that gain of function mutation of CARMA2 leads to spontaneous psoriasis-like skin inflammation by enhanced response to interleukin 17A.
RESULTS

Card14
E138A/+ and Card14 DQ136/+ Mice Spontaneously
Develop a Psoriasis-like Phenotype To investigate whether CARMA2 mutation directly contributes to psoriasis pathogenesis, we generated Card14 E138A/+ mice by using CRISPR-Cas9 gene-targeting approach, and accidently obtained CARMA2 Gln136-deleted (Card14 DQ136/+ ) mice (Figure S1A) . Of note, the survival rate of Card14 E138A/+ mice was significantly lower than Card14 DQ136/+ mice by the age of 3 weeks ( Figure S1B ), indicating that the pathogenesis of Card14 E138A/+ mice might be more severe than that of Card14 DQ136/+ mice.
E138A/+ heterozygous mice showed distinct redness and swelling of ears as well as obvious roughness of tails (Figure S1C) . Moreover, epidermal acanthosis was found by hematoxylin and eosin staining in the ear, tail and back at 20 days old ( Figure 1A ). Although CARMA2-Gln136 site was not reported as a susceptible mutation before, Card14 DQ136/+ mice also developed a relatively weaker psoriasis-like phenotype than Card14 E138A/+ mice with epidermal thickness only in the tails at 18 and 36 days old, while the ears appeared distinctly red and swollen until growing up to approximately 12 weeks old (Figures S1D and S1E). In human patients, psoriasis not only displays epidermis thickness, but also has other histological features of inflammation (Nestle et al., 2009; Perera et al., 2012) . To investigate whether CARMA2 mutation mice have similar histological features as in human patients, we stained the ear tissue sections and observed an increased expression of Ki67, K14, K10, and loricrin in Card14 E138A/+ mice compared with those of wild-type mice ( Figures 1B and 1C) . The similar results were found in the tails of Card14 DQ136/+ mice (Figures S1F and S1G). We next determined whether CARMA2-E138A mutation caused inflammation in the skin. As shown in Figure 1D , Card14 E138A/+ mice had an increased proportion and number of CD45 + leukocytes. Importantly, mRNA expression of Cxcl1, Ccl20, Il1b, Il6, Tnf, S100a8 , and S100a9 in the ears of Card14
and Card14 DQ136/+ mice was higher than that in wild-type mice ( Figure 1E and Figure S1H ). Altogether, these results show that Card14 E138A/+ and Card14 DQ136/+ mice develop spontaneous psoriasis-like phenotype, and CARMA2-E138A or DQ136 mutation is sufficient to drive the initiation of psoriasis.
ab T Cells Are the Main Source of IL-17A in Card14 E138A/+ Mice IL-17A antibody shows therapeutic effect in psoriasis patients and in IMQ-induced psoriasis-like model IL-17A was mainly secreted by gdT cells (Riol-Blanco et al., 2014) . First, we treated Card14 E138A/+ mice with IL-17A-blocking antibody and observed partial reduction of ear thickness in these mice (Figure 2A ), suggesting that IL-17A contributes to the development of psoriasis Figure 2C ), and the percentage and total number of infiltrated IL-17A + T cells was increased in the ears of Card14 E138A/+ mice ( Figure 2D ). Interestingly, we found most IL-17A + lymphocytes were ab T cells in the ears of Card14 E138A/+ mice ( Figure 2E ), whereas few conventional gd T cells secreted IL-17A ( Figure 2E ). Moreover, enhanced IL-23-IL-17 axis-related gene expression was observed in Card14 E138A/+ mice and Card14 DQ136/+ mice, such as Il23, Il17a, Il17f, and Il22 ( Figure 2F and Figure S1I ). The increase of Il17a, Il17f, and Il22 in Card14 DQ136/+ mice was significantly smaller than that in Card14 E138A/+ mice ( Figure 2F and Figure S1I ), which is correlated with the better survival rate of Card14 DQ136/+ mice ( Figure S1B ).
We also determined whether the systemic immune response was affected in Card14 E138A/+ mice. We compared the size and Figure S2 ). These observations indicate that CARMA2-E138A mutation induces the skin inflammation instead of influencing the development and response of central and peripheral immune system.
To further address whether T cells are essential for the development of CARMA2 E138A mutation-initiated psoriasis, we crossed Card14 E138A/+ mice with Rag1 À/À mice, but failed to obtain Card14 E138A/+ Rag1 À/À mice, which might be also due to the low survival rate of Card14 E138A/+ mice ( Figure S1B) as discussed above. However, when we bred Card14 Figure 2G ). This result indicates that T cells are important for the development of psoriasis and ab T cells are the main source of IL-17A in Card14 mutant mice.
Card14 Mutation in Non-Hematopoietic Cells Drives the Initiation of Psoriasis
We then examined what kinds of cells express Card14 mutation to drive the initiation of psoriasis. First, we analyzed the Card14 expression pattern in different tissues and found that Card14 was mainly expressed in skin compared with other CARMA family members ( Figure S3A ), particularly in epidermis ( Figure S3B ). Then, we sorted out different cell populations and observed a much higher Card14 expression level in primary keratinocytes compared with that in T or B cells ( Figure S3C ). Figure S3D ). These results indicate that the Card14 mutation expressed in non-hematopoietic cells plays a dominant role in psoriasis development. Both keratinocytes and T cells have been reported to be involved in psoriasis (Garber, 2012; Perera et al., 2012) . To confirm whether Card14 E138A/+ keratinocytes alone can develop psoriasis-like inflammatory response, we isolated the primary keratinocytes from the wild-type and Card14 E138A/+ newborn pups. Indeed, Card14 E138A/+ keratinocytes showed higher expression of Ccl20, S100a8, and S100a9 than the wild-type cells after culturing in vitro without any stimulation for a few days ( Figure S3E ). Upon IL17 stimulation, Card14 E138A/+ primary keratinocytes expressed even higher level of these genes than those in wild-type cells ( Figure S3F ). Taken together, these results showed that Card14 mutation expressed in non-hematopoietic cells, likely keratinocytes, is necessary for the initiation of psoriasis in Card14 E138A/+ and Card14 DQ136/+ mice.
The Activation of CARMA2 Mutants Is Due to Their Formation of Oligomers
Overexpression of CARMA2-E138A mutant in keratinocyte promotes the activation of NF-kB and MAPK signaling (Howes et al., 2016; Jordan et al., 2012b) . Consistently, we also observed constitutively activated NF-kB by co-expressing CARMA2 E138A or DQ136 mutants with NF-kB-dependent luciferase reporters ( Figure 3A ). To explore whether this hyper-activated NF-kB is required for the Card14 E138A/+ mice to develop psoriasis, we treated Card14 E138A/+ mice with NF-kB inhibitor, BAY11-7082. Upon treatment, attenuated skin phenotype of Card14 E138A/+ mice was observed ( Figure S4 ). These results indicate that NF-kB activation is required for the CARMA2 mutation-initiated psoriasis development. Next, we would like to determine the molecular mechanism by which CARMA2 mutant leads to the hyper-activated NF-kB. When detecting the NF-kB activation level in overexpressed CARMA2 mutants, we found that CARMA2 mutant proteins displayed much lower level than wild-type CARMA2 when lysed in low-detergent lysis buffer (PLB), but they were in comparable level when lysed in high-detergent sodium dodecyl sulfonate buffer (SDS) ( Figure 3A) , suggesting that CARMA2 mutations may form oligomers in cytoplasm as CARMA1 mutants do (Lenz et al., 2008) . To address this question, we examined cellular localization patterns of wild-type and mutated CARMA2 in 293T cells by fluorescence microscopy. We found that mutated CARMA2, but not wild-type, formed an aggregated structure near the perinuclear region ( Figure 3B ), which could also recruit and aggregate co-expressed MALT1, a signaling protein required for NF-kB activation ( Figure 3C ). In contrast, wild-type CARMA2 and its co-expressed MALT1 were diffused in cytoplasm ( Figure 3C ).
CARMA1 is kept in an inactive state through intramolecular interactions between the CARD domain and coiled-coil domain (Sommer et al., 2005) . Thus, we hypothesized that CARMA2 mutant disrupted the intramolecular interaction and caused self-aggregates. To test this hypothesis, we constructed a series of plasmids encoding different CARMA2 truncations ( Figure 3D ) and transfected these plasmids into 293T cells. We observed that fragments with aa1-999, aa1-854, aa1-677, aa1-123, aa401-577, aa115-577, and aa115-659 displayed diffused patterns in the cytoplasm while aa1-401 and aa115-401, as well as aa1-401 fragment carrying E138A or DQ136 mutation, were concentrated as aggregates near the nucleus, which demonstrated that it was the coiled-coil domain (aa115-401) responsible for protein oligomerization ( Figure 3E and Figure S5A ). By comparing the fluorescence patterns of aa115-401 and aa115-577, we found that the linker region (aa401-577) inhibited oligomerization ( Figure 3E ). Consistently, we found that only truncations containing the linker domain could be precipitated by aa1-401 ( Figure 3F ), indicating that the linker domain could associate with the coiled-coil domain. Together, our data indicated that CARMA2 mutant disrupted the intramolecular interaction between the coiled-coil domain and linker domain, which exposed the aggregation sites for CARMA2 oligomerization leading to the activation of NF-kB signaling ( Figure S5B ).
CARMA2 Deficiency Alleviates IMQ-Induced Epidermal Thickness
Our above data indicate that CARMA2-E138A mutation may drive the initiation of psoriasis. However, it is not clear whether CARMA2 is involved in the inflammatory feedback loop of psoriasis pathogenesis (Jordan et al., 2012a; Jordan et al., 2012b) . Thus, we generated Card14-deficient (Card14 À/À ) mice on C57BL/6 genetic background with a large fragment deletion between exon 2 and exon 4 of the genomic locus, which resulted in a frameshift mutation leading to an early translational termination ( Figures S6A-6C ). Since IMQ, a TLR7/8 ligand, induces the psoriasis-like skin inflammatory circuit via IL-23-IL-17 axis (Garber, 2012; van der Fits et al., 2009) . We next treated wild-type and Card14 À/À mice with IMQ on the backs or ears for 4 days. Erythema of skin was obvious on the back of wild-type mice but not in Card14 À/À mice, and ear swelling increased in wild-type mice along with time but not in Card14 À/À mice ( Figure 4A and Figure S6D ). Similarly, IMQ induced more swelling, epidermal (legend continued on next page) acanthosis, skin inflammation, and proliferation of keratinocytes in the back skin, and ears of wild-type mice than those of Card14 À/À mice ( Figure 4B and Figure S6E ). Moreover, the dorsal thickness of epidermis was dependent on IMQ dosage, but CARMA2 deficiency attenuated the IMQ-induced epidermis thickness ( Figure 4C ). To investigate the histological feature of wild-type and Card14 À/À mice in IMQ model, we stained the back skin and ear tissue sections. IMQ-treated Card14 À/À mice showed reduced Ki67 + cells ( Figure 4D ), whereas dorsal skin from Card14 À/À mice expressed higher level of Keratin 10 (K10) but lower level of Keratin 14 (K14) in epidermal layers than wildtype mice ( Figure 4D and Figure S6F ). We also observed nearly no loricrin expression in wild-type mice ( Figure 4D ). Consistently, the mRNA expression of K10 and loricrin were also relatively higher in IMQ-treated Card14 À/À mice ( Figure 4E and Figure 5A and Figure S7A ). IMQ treatment also increased the percentage and total number of CD45 + cells in wild-type mice compared to Card14 À/À mice ( Figure 5B ). These cells revealed higher infiltration of CD11b + Ly6G + neutrophils and CD11b + F4/80 lo monocytes but not CD11b + F4/80 hi macrophages ( Figure 5C ). Next, we investigated whether CARMA2 controls the expression of inflammatory mediators in the skin. Indeed, Card14 À/À mice showed decreased expression of Cxcl1, Ccl20, S100a8, S100a9, Il6, and Il1b, but a similar level of Tnf in the ears compared to wild-type mice ( Figure 5D and Figure S7B ). We also found decreased genes expression related to the IL-23-IL-17 axis, such as Il23, Il17a, Il17f, and Il22, which hint a role of CARMA2 in the IL-23-IL-17 axis ( Figure 5E ). Figure 6E ). Moreover, we also found that IMQ treatment increased the expression of Il23 to a similar extent in both genotypes at 3h ( Figure 6F ). Since IMQ-induced Il23 expression was not significantly affected in Card14 À/À DCs in vitro ( Figure 6G ), we propose a model that IMQ treatment induced the activation of DCs, after which T cells were recruited and secreted IL17a to act on keratinocytes, where CARMA2 was involved to contribute to the activation of NK-kB-related inflammatory response ( Figure 6H ). This circuit would propel the pathogenesis of psoriasis.
CARMA2 Regulated the IL-17A Signaling in Keratinocytes
Since Cxcl1, Ccl20, S100a8, and S100a9 are the target genes of IL-17A in keratinocytes (Gaffen et al., 2014) and IMQ-induced expression of these mediators were significantly reduced in Card14 À/À mice ( Figure 5D ), we hypothesized that CARMA2 was involved in the IL-17A signaling in keratinocytes. To test this hypothesis, we isolated primary keratinocytes and stimulated them with IL-17A in vitro. IL-17A induced lower Ccl20, S100a8, and S100a9 expression in CARMA2-deficient keratinocytes than wild-type cells, while both genotypes showed similar expression of Cxcl1 ( Figure 7A ). The induction of Cxcl1, Ccl20, S100s8, and S100a9 by IL17A was dependent on NF-kB activation, since treatment with NF-kB inhibitor (TPCA-1) suppressed their mRNA expression ( Figure 7B ). To determine whether CARMA2 is involved in IL17A-induced signaling, we stimulated primary keratinocytes with IL17A, and found that both IL17A-induced phosphorylation of IkBa, p65, p38, and JNK, as well as IkBa degradation was reduced in CARMA2-deficient cells ( Figure 7C ). It is known that TRAF6 can interact with ACT1 upon IL17A stimulation (Gaffen et al., 2014; Scudiero et al., 2011) , and plays an important role in the CARMA1 regulated signaling pathway (Blonska and Lin, 2011 (E) Quantitative PCR analysis of mRNA level of the indicated genes in ear skin treated with IMQ at 0, 6, and 36 hr time point. Results (calculated by the change-incycling-threshold (2ÀDDCt) method) are normalized to internal control gene Gapdh.
(legend continued on next page)
We next examined whether CARMA2 could associate with ACT1 and TRAF6. When CARMA2 and ACT1 or TRAF6 were co-expressed in 293T cells, we observed a strong interaction between CARMA2, ACT1, and TRAF6, respectively ( Figure 7D ). The interactions between these three proteins were examined in a doxicycline-induced-CARMA2-expression HacaT stable cell line. Their basal interaction level depended on the CARMA2 expression level ( Figure 7E ). Consistent with above data that CARMA2 plays an important role in IL-17A signaling, IL17A stimulation could enhance the association of ACT1 with CARMA2 and TRAF6 ( Figure 7F ). Together, these results indicate that CARMA2 is a signaling component interacting with the ACT1-TRAF6 complex to regulate IL-17A signaling.
DISCUSSION
The adaptive immune system has been considered as the main driver of psoriasis over the past two decades (Garber, 2012) . Clinical usage of IL-23 antagonists (Crow, 2012b; Reich et al., 2017) or IL-17 antagonists (Lebwohl et al., 2015; Mease et al., 2017; van de Kerkhof et al., 2016) highlights the importance of IL-23-IL-17 axis in psoriasis pathogenesis (Kim and Krueger, 2017; Riol-Blanco et al., 2014) . However, GWAS studies with psoriasis patient samples not only mapped to IL-23-IL-17 axis genes, but also identified multiple loci relevant to NF-kB signaling pathway (Harden et al., 2015; Tsoi et al., 2012) . This indicates an important role of NF-kB activation in keratinocytes in psoriasis pathogenesis. Previous studies reported that CARD14 mutations were linked to pathogenesis of psoriasis, and CARMA2 is a protein mainly expressed in epidermis and mucosal tissues (Jordan et al., 2012b; Tsoi et al., 2012) . In this study, we showed that expression of constitutively active mutants (E138A or DQ136) of CARMA2 expressed in non-hematopoietic cells, likely keratinocytes, was sufficient to initiate psoriasis in mice. Our studies showed that Card14 E138A/+ and Card14 DQ136/+ mice could spontaneously develop a psoriasis-like phenotype, which supports the hypothesis that the innate immunity initiated from keratinocytes may drive the initiation of psoriasis. However, the rescued phenotype in Card14 DQ136/+ Rag1 À/À mice revealed an essential role of T cells in the progress of psoriasis. Consistently, our data revealed that CARMA2 deficiency alleviated IMQ-induced psoriasis-like skin inflammation in vivo. Importantly, we linked CARMA2 into the IL17A signaling pathway, because we observed reduced Ccl20, S100a8, and S100a9 expression and reduced degradation of IkBa and phosphorylation of p65 and JNK in murine primary keratinocytes stimulated with IL17A in vitro. Mechanistically, we found that CARMA2 could associate with the ACT1-TRAF6 complex, two crucial signaling components in IL17A signaling. Combining all of these results, we demonstrate that CARMA2 plays a pivotal role in the psoriasis inflammatory circuit.
One group reported that the size of spleen and skin-draining lymph node increased in IMQ-induced psoriasis-like model (van der Fits et al., 2009) , the exact role of these immune organs during psoriatic inflammation is not clear (Riol-Blanco et al., 2014) . However, in our study, we found that both the size and cell proportion of spleen, thymus as well as axillary, inguinal, cervical, and mesenteric lymph nodes have no significant differences between 30-day-old wild-type and Card14 E138A/+ mice, and the bone marrow chimera assay also indicates that CARMA2 in hematopoietic cell is not essential in psoriasis development. This is consistent with another finding that deficiency of lymph nodes did not affect the ear thickness in IMQ-induced psoriasis-like model (Riol-Blanco et al., 2014) , but differs from findings in another study, which indicated that the CARMA2 in T cell is important in the IMQ-induced psoriasis model (Tanaka et al., 2018) . These data suggest that the peripheral immune organs only play a limited role in the development of psoriasis pathogenesis.
The ACT1 SNP (D10N) was identified by GWAS studies in psoriasis patients (Tsoi et al., 2012) , and ACT1 epidermal-specific knockout mice displayed attenuated psoriatic inflammation in response to IMQ (Ha et al., 2014) . Similar with Act1-deficient mice, Card14-deficient mice also showed attenuated psoriatic inflammation and epidermal thickness in response to IMQ by disrupting the IL-17A signaling. ACT1 is an important adaptor in IL-17 family members (Gaffen et al., 2014) . It will be interesting to determine whether CARMA2 also participates in signaling pathways induced by other IL-17 family members besides IL-17A. CARMA family proteins share high degree of sequence and structure homology and play similar roles in different cell types (Blonska and Lin, 2011) . It will be also important to determine whether other CARMA family members function downstream of IL-17A signaling in other cell types.
NF-kB is an important family of transcription factors, which regulates the biological process of cell survival, cell proliferation, inflammation, and other immune responses. Nevertheless, the role of NF-kB activation and skin inflammation in psoriasis development is somewhat controversial. We found that CARMA2-E138A mutation hyper-activated the NF-kB in keratinocytes, which results in epidermis hyperplasia and skin inflammation in Card14 E138A/+ mice. Consistently, Page et al. found that the K5-IKKb transgenic mice with increased NF-kB signaling in skin basal cells showed skin inflammation and epidermis hyperplasia (Page et al., 2010) . However, it has been reported that mice with epidermis-specific deletion of IKKb, which shows impaired NF-kB activation, also develop a severe inflammatory skin disease, revealed by a markedly thickened epidermis (Pasparakis et al., 2002) . Therefore, it will need to be determined why both enhanced NF-kB signaling and defective NF-kB signaling both lead to skin inflammation. Many studies use the IMQ treatment mouse model to investigate psoriasis. In this acute inflammation model, mice start to develop ear swelling, skin erythema, and inflammation only 3 days after IMQ treatment (Riol-Blanco et al., 2014; van der Fits et al., 2009 ). However, for psoriasis patients, there is a complex interplay between the innate and adaptive arms of the immune system in response to an unidentified trigger (Perera et al., 2012) . Card14 E138A/+ mice start to show spontaneous psoriasis-like phenotype, such as ear redness and swelling, tail roughness, higher expression of K10 and loricrin in epidermis, and increased infiltration of Th17-producing cells at about 20 days old. Importantly, treatment of Card14 E138A/+ mice with IL-17A blocking antibody partially inhibits the psoriasis progression in these mice, indicating that symptoms in Card14 E138A/+ mice more closely resemble psoriatic characteristics in human patients. Therefore, Card14 E138A/+ mice will be an excellent model for studying the molecular mechanism of psoriasis development and preclinical drug tests. Moreover, CARMA2 is required for the IL-17A downstream signaling, and Card14-deficient mice show impaired keratinocyte proliferation and skin inflammation upon IMQ-treatment, suggesting that inhibitors for CARMA2-associated signaling may be a promising therapeutic target for the treatment of psoriasis.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Experimental Animals All mice used in this study were on the C57BL/6 background. Card14 
Il17a
À/À mice. Mice were bred and maintained under specific-pathogen-free condition at Tsinghua University. Unless otherwise stated, male and female mice were sex-matched and used at 6-12 weeks of age. The mouse experiments were carried out in accordance with the institutional guidelines and were approved by the Institutional Animal Care and Use Committees at Tsinghua University.
Cell Lines
HEK293T and HacaT cells were cultured in DMEM (GIBCO) supplemented with 10% FBS. All cells were cultured at 37 C and 5% CO 2 .
Primary Cell Cultures
Primary keratinocytes were isolated from newborn pups and cultured as described in In vitro Keratinocytes Isolation and Cell Culture below. Cells were cultured at 37 C and 5% CO 2 .
METHOD DETAILS
Generation of Card14 -/-Mice C57BL/6 mice were kept and bred under specific pathogen-free (SPF) conditions. Animal care and experiments were undertaken in compliance with National Institute of Health Guide and the guideline of Animal Care Committee of Sun Yat-sen University. The pT7-3XFlag-hCas9 plasmid was linearized with PmeI to synthesis Cas9 mRNA using the mMACHINE T7 ULTRA kit (Life Technologies). The pDR274 vector encoding gRNA sequences was in vitro transcribed using the MEGAshortscript T7 kit (Life Technologies). The Cas9 mRNA and the gRNAs were subsequently purified with the MEGAclear kit (Life Technologies), resuspended in RNase-free water, and quantified using NanoDrop-1000. The mixture of Cas9 mRNA and gRNA was injected into 0.5-day zygotes of C57BL/6J mice. 3 hours after injection, the injected zygotes were transplanted into the oviduct of 0.5-day pseudopregnant mother. CRISPR/Cas9 knockout founder mice were bred with wild-type mice to generated F1 generation mice.
Generation of Card14
DQ136/+ and Card14 E138A/+ Mice Card14 DQ136/+ and Card14 E138A/+ mice were also generated on C57BL/6 background using CRISPR/Cas9 methodology.,
A Card14 DQ136/+ mouse was accidentally got simultaneously with Card14 E138A/+ mice using a sgRNA designed for Card14 E138A/+ mice. The sgRNA targeting sequence (Table S1 ) was designed using the CRISPR tool (http://crispr.mit.edu/), which was then synthesized by using spCas9-gRNA efficiency of target detection kit (Viewsolid Biotech). Next, sgRNA and Cas9 mRNA were transcribed in vitro using MEGAshortscript T7 Transcription Kit and mMESSAGE mMACHINEÒ T7 ULTRA Transcription Kit (Life Technologies) based on manufacture's protocol, respectively. Both sgRNA and Cas9 mRNA were purified using MEGAclear Kit (Life Technologies) and eluted in RNase-free water. Donor DNA (Table S1 ), single strand oligodeoxynucleotides (120bp) containing c.413A>C (p.Glu138Ala) point mutation was synthesized in Sangon Biotech (shanghai China). To increase the knock-in efficiency and prevent the sgRNA-directed Cas9 from cleaving mutant CARMA2 genomic locus, we also constructed 5 synonymous mutations within the donor. A total 20 mL of mixture containing sgRNA (20ng/ml), Cas9 mRNA (40ng/ml), and donor oligodeoxynucleotides (60ng/ml) was injected into zygotes by pronuclear microinjection technology. To genotype the founder mice, genomic fragments were amplified from tail DNAs using manually designed specific primers (Table S1) , then detected by DNA gel (YEASEN) and confirmed by TA cloning (Transgen).
Imiquimod Model of Skin Inflammation IMQ-induced psoriasis-like disease model was performed as described previously (van der Fits et al., 2009) . Otherwise stated, wildtype and Card14 À/À mice were received a daily topical dose of 30mg IMQ cream (5%; Aldara; 3M Pharmaceuticals) on the shaved dorsal skin or 25mg on ears for 3-5 days. Control mice were conducted similarly without IMQ treatment. Ear thickness were measured with an engineer's caliper daily. Samples were taken 1 day later after the last treatment.
Bone Marrow Chimeras and CD90.2 + T Cell Transfer
For bone marrow chimeras, 8-week-old recipient mice were lethally irradiated by X-ray (550 rad 3 2), and received 5 3 10 6 bone marrow leukocytes from indicated donors by intravenous (i.v.) injection. Chimeras were used for further experiments 7-8 weeks after initial reconstitution. For CD90.2 + T cell transfer, the T cells was purified by using EasySep Mouse CD90.2 Pos Slctn Kit II, and count the cell number using the C6, then 16-week-old Card14 DQ136/+ Rag1 À/À was received 2x10 6 CD90.2 + T cell from indicated donors by intravenous (i.v.) injection.
In vitro Keratinocytes Isolation and Cell Culture Keratinocytes were isolated from the skin of newborn pups (1-3 days of age). Skin was incubated in 0.25% trypsin (without EDTA) or 1mg/ml Dispase II (Roche) overnight at 4 C. The next day, the epidermis peeled off from the dermis, subsequently digested with 0.05% trypsin for 10min at 37 C and filtered with a 100 mm strainer. For IL17A stimulation, isolated cells at a density of 10 6 cells/ well cultured with K-SFM (Life Technologies) in 12-well plates and used between 3 and 5 days after isolation.
Flow Cytometry
Lymph nodes and spleen were mechanically dissociated to obtain single-cell suspensions, and splenic cells were treated with RBC lysis buffer to deplete red blood cells. For total ear samples of single-cell suspensions, animals were euthanized and ears were collected and digested with 3mg/ml Collagenase D (Roche) and 10mM DNase I (Roche) in free-serum medium RPMI for 60 min at 37 C. Enzyme activity was inhibited by adding 10 mL of PBS supplemented with 1% of FBS. The tissues then were mechanically disrupted and filtered through 100 mm cell strainer to obtain single-cell suspension. For epidermis and dermis single-cell suspensions respectively, ear samples incubated with Dispase II (3mg/ml in free-serum medium RPMI, Roche) for 60 min at 37 C. The two layers were then separated with forceps. Epidermis was directly homogenized while dermis was re-treated with 3mg/ml Collagenase D (Roche) and 10mM DNase I (Roche) in free-serum medium RPMI for 60min at 37 C before filtered with 100 mm strainers. For surface staining, cells were stained with antibodies against surface antigens in FACS buffer (PBS supplemented with 1% FBS) on ice for 30 min using appropriate antibodies. Viability dye (eBioscience) was used to exclude dead cells. For intracellular cytokine staining, cells were fixed and permeabilized with BD Cytofix/Cytoperm solution followed by staining with antibodies against cytokines in Perm/Wash buffer (BD Biosciences).
RNA Isolation and Quantitative RT-PCR
Snap-frozen mouse ear tissues were ground in liquid nitrogen and dissolved directly in TRIzol (Invitrogen). Total RNA was extracted and reverse transcription was performed using RevertAid First Strand cDNA Synthesis Kit (Thermo Scientific) according to the manufacturer's instructions. An ABI 7500 Real-Time PCR system (Applied Biosystems) and Power SYBR Green PCR Master Mix (Genestar) were used for qPCR. Results were normalized to Gapdh and quantification was carried out using the 2 -DDCt method.
Melting curves were confirmed to ensure amplification of a single product. Primers used in this paper are listed in Table S2 .
Histopathology, Immunohistochemistry, and Immunofluorescence For histopathology analysis, mouse dorsal skin, ear and tail tissues were fixed with 4% formaldehyde overnight followed by dehydrated and embedded in paraffin. The 5-mm tissue sections were stained with hematoxylin and eosin according to standard procedures. Stained sections were scanned using an Olympus microscope (IX73). The epithelial thickness was evaluated in more than 12 independent regions. For immunohistochemistry and immunofluorescence, 4% formaldehyde-fixed paraffin-embedded dorsal skin, ear and tail sections were deparaffinized, and antibody retrieved with sodium citrate, then stained with Ki67 (abcam), K14 (abcam), K10 (abcam), Loricrin (abcam), CD45 (Ceville), CD11c (Ceville), F4/80 (Ceville) and Ly6G (Ceville). The images were captured with an Olympus microscope (IX73).
Western Blot and Immunoprecipitation
Mouse keratinocytes were starved overnight, then stimulated with IL17A at the indicated time points. Cells were collected with lysis buffer (150 mM NaCl, 50 mM HEPES, pH 7.4, 1 mM EDTA, 1% Nonidet P-40, and protease inhibitors). Total cell lysates were subjected to SDS-PAGE and then blotted using the indicated antibodies. For immunoprecipitation, Various epitope-tagged constructs were transfected into HEK293T cells. After 24h incubation, cells were lysed in lysis buffer (250 mM NaCl, 50 mM HEPES, pH 7.4, 1mM
